Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients with Breast Cancer

Launched by OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER · Mar 23, 2015

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help women with breast cancer stick to their prescribed hormonal therapy after their initial treatment. The study is testing a telephone-based program that encourages better communication between doctors and patients. By using phone calls and text messages, the hope is that patients will feel more supported and motivated to take their medication as directed. This is particularly important for women who have completed their primary treatment and are starting hormonal therapy for the first time.

To be part of this trial, women need to be post-menopausal and diagnosed with early to mid-stage breast cancer (stages I to III). They should also own a smartphone since they will receive messages through an app over three months. Participants will need to agree to share their medical records and stay in the study area during this time. The trial is currently recruiting women aged 65 to 74 who are interested in participating. This study could provide valuable support to women navigating their treatment journey.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• * Eligible women are those who:
• * Are post-menopausal, verified by:
• • Post bilateral surgical oophorectomy; or
• • No spontaneous menses \>= 1 year; or
• • No menses for \< 1 year with follicle stimulating hormone (FSH) and estradiol levels in postmenopausal range, according to institutional standards
• • Are diagnosed with primary breast cancer (BC) (stages I-III)
• • Eligible to receive AHT (tamoxifen or an aromatase inhibitors \[AI\]) for the first time
• • Completed all primary treatment
• • Own a smartphone (in order to receive text messages and utilize the phone app)
• • Agree to receive text messages on their smartphone over a 3-month period
• • Provide consent and permission to review their medical records
• • Plan to stay in the study area for 3 months